Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways

Journal of Experimental Medicine

Volumn 187, Issue 1, 1998, Pages 1-14

  Salazar Mather, Thais P ^a   Orange, Jordan S ^a   Biron, Christine A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RNA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION; HEPATITIS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; CELL MOVEMENT; FEMALE; GENES, RAG-1; HERPESVIRIDAE INFECTIONS; INFLAMMATION; KILLER CELLS, NATURAL; LIVER; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, KNOCKOUT; MICE, NUDE; MICE, SCID; MUROMEGALOVIRUS;

EID: 0031974018     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.1.1     Document Type: Article

References (51)

1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187-376.
2. Wiltrout, R.H., A.M. Pilaro, M.E. Grays, J.E. Talmadge, D.L. Longo, J.R. Ortaldo, and C.W. Reynolds. 1989. Augmentation of mouse liver-associated natural killer cell activity by biological response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow. J. Immunol. 143:372-378.
3. McIntyre, K.W., and R.M. Welsh. 1986. Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection. J. Exp. Med. 164:1667-1681.
4. Biron, C.A. 1997. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9: 24-34.
5. Ten Napel, H.H., H.J. Houthoff, and T.H. The. 1984. Cytomegalovirus hepatitis in normal and immune compromised hosts. Liver. 4:184-194.
6. Paya, C.V., P.E. Hermans, R.H. Wiesner, J. Ludwig, T.F. Smith, J. Rakela, and R.A. Krom. 1989. Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J. Infect. Dis. 160:752-758.
7. Betts, R.F., and J.B. Hanshaw. 1977. Cytomegalovirus (CMV) in the compromised host(s). Annu. Rev. Med. 28: 103-110.
8. Stagno, S., R.F. Pass, M.E. Dworsky, R.E. Henderson, E.G. Moore, P.D. Walton, and C.D. Alford. 1982. Congenital cytomegalovirus infections: the relative importance of primary and recurrent maternal infections. N. Engl. J. Med. 306:945-949.
9. Drew, W.L. 1988. Cytomegalovirus infection in patients with AIDS. J. Infect. Dis. 158:449-456.
10. Biron, C.A., K.S. Byron, and J.L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731-1735.
11. McCordock, H.A., and M.G. Smith. 1936. The visceral lesions produced in mice by the salivary gland virus of mice. J. Exp. Med. 63:303-310.
12. Henson, D. R.D. Smith, and J. Gehrke. 1966. Non-fatal mouse Cytomegalovirus hepatitis: combined morphologic virologic and immunologic observations. Am. J. Pathol. 49: 871-888.
13. Reynolds, R.P., R.J. Rahija, D.I. Schenkman, and C.B. Richter. 1993. Experimental murine cytomegalovirus infection in severe combined immunodeficient mice. Lab. Anim. Sci. 43:291-295.
14. Shanley, J.D., L. Biczak, and S.J. Forman. 1993. Acute murine Cytomegalovirus infection induces lethal hepatitis. J. Infect. Dis. 167:264-269.
15. Orange, J.S., T.P. Salazar-Mather, S.M. Opal, and C.A. Biron. 1997. Mechanisms for virus-induced liver disease: a TNF-mediated liver pathology independent of NK and T cells during murine cytomegalovirus infection. J. Virol. 71: 9248-9258.
16. Bancroft, G.J., G.R. Shellam, and J.E. Chalmer. 1981. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J. Immunol. 126:988-994.
17. Bukowski, J.F., B.A. Woda, S. Habu, K. Okumura, and R.M. Welsh. 1983. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 131:1531-1538.
18. Bukowski, J.F., B.A. Woda, and R.M. Welsh. 1984. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52:119-128.
19. Orange, J.S., B. Wang, C. Terhorst, and C.A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this pathway by interleukin 12 administration. J. Exp. Med. 182:1045-1056.
20. Orange, J.S., and C.A. Biron. 1996. An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. J. Immunol. 156:1138-1142.
21. Orange, J.S., and C.A. Biron. 1996. Characterization of early IL-12. IFN-α/β. and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:4746-4756.
22. Tay, C.H., and R.M. Welsh. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71:267-275.
23. Ruzek, M.C., A.M. Miller, S.M. Opal, B.D. Pearce, and C.A. Biron. 1997. Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J. Exp. Med. 185:1185-1192.
24. Olver, S.D., V. Price, and G.R. Shellam. 1994. Cytomegalovirus hepatitis: characterization of the inflammatory infiltrate in resistant and susceptible mice. Clin. Exp. Immunol. 98: 375-381.
25. Cook, D.N., M.A. Beck, T.M. Coffman, S.L. Kirby, J.F. Sheridan, I.B. Pragnell, and O. Smithies. 1995. Requirement of MIP-1α for an inflammatory response to viral infection. Science. 269:1583-1585.
26. Oppenheim, J.J., C.O.C. Zachariae, N. Mukaida, and K. Matsushima. 1991. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9:617-648.
27. Brown. K.D., S.M. Zurawski, T.R. Mossman, and G. Zurawski. 1989. A family of small inducible proteins secreted by leukocytes are members of a new superfamily that include leukocyte and fibroblast-derived inflammatory agents growth factors and indicator of various activation processes. J. Immunol. 142:679-687.
28. Maghazachi, A.A., A. Al-Aoukaty, and T.J. Schall. 1994. C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. J. Immunol. 153:4969-4977.
29. Taub, D.D. T.J. Sayers, C.R.D. Carter, and J.R. Ortaldo. 1995. α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155:3877-3888.
30. 2+ mobilization, and enzyme release. J. Immunol. 156:322-327.
31. Mombaerts, P., J. Iacomini, R.S. Johnson, K. Herrup, S. Tonegawa, and V.E. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 68:868-877.
32. Wang, B.C., C. Biron, J. She, K. Higgins, M-J. Sunshine, E. Lacy, N. Lonberg, and C. Terhorst. 1994. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3∈ gene. Proc. Natl. Acad. Sci. USA. 91:9402-9406.
33. Su, H.C., J.S. Orange, L.D. Fast, A.T. Chan, S.J. Simpson, C. Terhorst, and C.A. Biron. 1994. IL-2-dependent NK cell responses discovered in virus-infected β2-microglobulin-deficient mice. J. Immunol. 153:5674-5681.
34. Salazar-Mather, T.P., R.I. Ishikawa, and C.A. Biron. 1996. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection J. Immunol. 157-3054-3064.
35. Austyn, J.M., and S. Gordon. 1981. F4/80: a monoclonal antibody directed specifically against mouse macrophages. Eur. J. Immunol. 10:805-810.
36. Smith, R.E., K.M. Strieter, S.H. Phan, N.W. Lukacs, G.B. Huffnage, C.A. Wilke, M.D. Burdick, P. Lincoln, H. Evanoff, and S.L. Kunkel. 1994. Production and function of murine macrophage inflammatory protein-1α in bleomycin-induced lung injury. J. Immunol. 153:4704-471
37. Orange, J.S., T.P. Salazar-Mather, S.M. Opal, R.L. Spencer, A.H. Miller, B.S. McEwen, and C.A. Biron. 1995. Mechanic of IL-12-mediated toxicities during experimental viral infections: role of TNF and glucocorticoids. J. Exp. Med. 181:901-914.
38. Rhoades, E.R., A.M. Cooper, and I.M. Orme. 1995. Chemokine response in mice infected with Mycobacterium tuberculosis. Infect. Immun. 63:3871-3877.
39. MacDonald, M.R., X.Y. Li, and H.W. Virgin IV. 1997. Late expression of a beta chemokine homolog by murine cytomegalovirus. J. Virol. 71:1671-1678.
40. Gao, J.L., and P.M. Murphy. 1994. Human cytomegalovirus open reading frame US28 encodes a functional β chemokine receptor. J. Biol. Chem. 268:28539-28542.
41. Graham, K.A., A.S. Lalani, J.L. Macen, T.L. Ness, M. Barry, L.Y. Liu, A. Lucas, I. Clark-Lewis, R.W. Mover, and G. McFadden. 1997. The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology. 229:12-24.
42. Davis-Poynter, N.J., D.M. Lynch, H. Vally, G.R. Shellam, W.D. Rawlinson, B.C. Barrell, and H.E. Farrell. 1997. Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus. J. Virol. 71:1521-1529.
43. Amichay, D., R.T. Gazzinelli, G. Karupiah, T.R. Moench, A. Sher, and J.M. Farber. 1996. Genes for chemokines mumig and crg-2 are induced in protozoan and viral infections in response to IFN-γ with patterns of tissue expression that suggest nonredundant roles in vivo J. Immunol. 157:4311-4520.
44. Lukacs, N.W., R.M. Strieter, V.M. Elner, H.L. Evanoff, M. Burdick, and S.L. Kunkel. 1994. Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1α during monocyte-endothelial cell interactions. Blood. 583:1174-1178.
45. Bluman, E.M., K.J. Bartynski, B.R. Avalos, and M.A. Caliguri. 1996. Human natural killer cells produce abundant macrophage inflammatory protein-1α in response to monocyte-derived cytokines J. Clin. Invest. 97:2722-2727.
46. Karupiah, G., Q.W. Xie, R.M. Buller, C. Nathan, C. Duarte, and I.D. MacMicking. 1993. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science. 261:1445-1448.
47. Bi, Z., and C.S. Reiss. 1995. Inhibition or vasicular stomatitis virus infection by nitric oxide. J. Virol. 69:2208-2213.
48. Selgrade, M.K., and J.E. Osborn. 1974. Role of macrophages in resistance to murine cytomegalovirus. Infea. Immun. 10: 1383-1390.
49. Price, P., J.G. Winter, and G.R. Shellam. 1987. Genetically determined resistance to murine cytomegalovirus: a role for lymphocytostatic macrophages. J. Gen. Virol. 68:2997-3008.
50. Heise, M.T., and H.W. Virgin IV. 1995. The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J. Virol. 69:904-909.
51. Ding, A.H., C.F. Nathan, and D.J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141: 2407-2412.